Opiant Pharmaceuticals (OPNT) Tops Q3 EPS by 85c
Tweet
Share
E-mailGet Alerts OPNT Hot Sheet
Price: $20.65 --0%
Financial Fact:
Professional services: 4.79M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Professional services: 4.79M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Opiant Pharmaceuticals (NASDAQ: OPNT) reported Q3 EPS of $0.77, $0.85 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.3 million versus the consensus estimate of $10.21 million.
For earnings history and earnings-related data on Opiant Pharmaceuticals (OPNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
